Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0691 per EA under NDC 59651005205. Its NADAC has been published 433 times since Mar 14, 2018.
Strength
10 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651005205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA209838On Market Since
8/25/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 433 times since Mar 14, 2018, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0691 per EA |
|---|---|
| All-time high | $0.3870 (Mar 14, 2018) |
| All-time low | $0.0687 (Oct 22, 2025) |
| 52-week high | $0.0763 |
| 52-week low | $0.0687 |
| Median price | $0.1047 |
| Average price | $0.1353 |
| Largest weekly change | +22.7% (Jun 19, 2024) |
| Weeks tracked | 433 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0691 per EA (NDC 59651005205), effective Jun 24, 2026.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 82.1%. It has been tracked across 433 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Mar 14, 2018, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0687 (Oct 22, 2025) to a high of $0.3870 (Mar 14, 2018), with a median of $0.1047 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as EZETIMIBE 10 MG TABLET, but none are currently priced below it.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 59651005205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification